Making life beyond cancer a reality. fredhutch.org
Fred Hutch
Loading...
Join Fred Hutch Cancer Center and UW Medicine for the 17th Annual Hematology & Oncology Review Course, October 12-16 in Seattle.
📢 Early bird pricing is available now through June 17 — save $100 on all registration categories.
Register: https://bit.ly/4nU0pU7
This afternoon at #ASCO! Hear from Fred Hutch's Senior Vice President and Director of the Clinical Research Division, Dr. Sara Hurvitz. https://bit.ly/49YIxlj
ICYMI, catch the latest episode of the Oncology Insights podcast with Drs. Petros Grivas and Vyshak Venur to learn more about ongoing #clinicaltrials in neuro-oncology, the importance of multidisciplinary care, improving community outreach and more. https://bit.ly/4ed9ncd
Congrats to Dr. Nancy Davidson on receiving the David Karnofsky Science of #Oncology Award, @ascocancer.bsky.social's highest scientific honor.
Dr. Davidson’s decades of research have shaped how the world treats #breastcancer.
https://bit.ly/43dWY1j
The future of cancer care might lie in the gut.
Researchers like Fred Hutch's Dr. Armin Rashidi are leading the way, studying how restoring microbial balance could reduce complications and improve outcomes for people with blood cancers. https://cnn.it/4xh4czm
“Here at Fred Hutch, we’re very good with highlighting all that our researchers are doing, but I think there’s a huge opportunity to shift that to our nurses who are also doing this incredible work,” said Rainier Achacoso, DNP, MBA, MSN, RN, NE-BC. https://bit.ly/3S3fPcR
“It’s a paradigm shifting treatment,” said Fred Hutch's Dr. Andrew Coveler. “It’s going to probably change treatment from chemotherapy to agents that target the mechanism that causes pancreas cancer.” https://bit.ly/4usynkv
The future of cancer care might lie in the gut.
Researchers like Fred Hutch's Dr. Armin Rashidi are leading the way, studying how restoring microbial balance could reduce complications and improve outcomes for people with blood cancers. https://cnn.it/4xh4czm
Fred Hutch at #ASCO26: @mshadman.bsky.social shares SEQUOIA data on subsequent therapies & PFS2 in TN CLL/SLL — comparing prior zanubrutinib vs bendamustine-rituximab. 🔗 www.asco.org/abstracts-pr...
Fred Hutch
Fred Hutch
Fred Hutch
Fred Hutch
Fred Hutch
Fred Hutch
Fred Hutch
Fred Hutch
Fred Hutch
Nancy E. Davidson, MD, executive vice president and chief academic officer at Fred Hutch Cancer Center, is the recipient of the David Karnofsky Science of Oncology Award from the American Society for Clinical Oncology (ASCO).
Fred Hutch’s Drs. Petros Grivas and Vyshak Venur discuss clinical trials, multidisciplinary care and community outreach in neuro oncology.
bit.ly
Fred Hutch Cancer Center has increased financial and administrative support for oncology nurses eager to flex their research muscles by publishing articles in peer-reviewed journals and presenting at ...
